{"transactions":[{"id":4637407,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-10-07T22:20:34.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":2006,"price":4.63,"value":9287.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.54 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":2792690,"source":{"system":"sec-edgar","filing":"0001839066-26-000054","document":"wk-form4_1791411631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1839066/000183906626000054/wk-form4_1791411631.xml","form_type":"4"}},{"id":4631260,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-10-05T23:00:53.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":8750,"price":4.42,"value":38675.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting of 6.25% of restricted stock units (the \"RSUs\") on October 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023, with a final vesting on January 3, 2027, subject to the continued service of the Reporting Person on such final vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":2794696,"source":{"system":"sec-edgar","filing":"0001839066-26-000052","document":"wk-form4_1791241251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1839066/000183906626000052/wk-form4_1791241251.xml","form_type":"4"}},{"id":4622893,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:22:45.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":1921,"price":4.56,"value":8759.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."}],"balance_after":2803446,"source":{"system":"sec-edgar","filing":"0001839066-26-000047","document":"wk-form4_1789762962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1839066/000183906626000047/wk-form4_1789762962.xml","form_type":"4"}},{"id":4618739,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-09-15T23:48:03.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":9273,"price":4.78,"value":44324.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the final 6.25% of restricted stock units (the \"RSUs\") on September 15, 2026. The RSUs were originally granted to the Reporting Person on September 16, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":2805367,"source":{"system":"sec-edgar","filing":"0001839066-26-000045","document":"wk-form4_1789516081.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1839066/000183906626000045/wk-form4_1789516081.xml","form_type":"4"}},{"id":706289,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-07-17T21:26:40.000Z","date":"2026-07-17","kind":"sale","planned":true,"acquired":false,"shares":4839,"price":4.53,"value":21920.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.35 to $4.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":2814640,"source":{"system":"sec-edgar","filing":"0001839066-26-000039","document":"wk-form4_1784323597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000039/wk-form4_1784323597.xml","form_type":"4"}},{"id":707794,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-07-16T20:50:04.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":13119,"price":4.67,"value":61265.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the \"RSUs\") on July 15, 2026. The RSUs were originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":2819479,"source":{"system":"sec-edgar","filing":"0001801170-26-000176","document":"wk-form4_1784235002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000176/wk-form4_1784235002.xml","form_type":"4"}},{"id":711590,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-07-09T20:45:40.000Z","date":"2026-07-08","kind":"sale","planned":true,"acquired":false,"shares":2384,"price":4.68,"value":11157.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."}],"balance_after":2832598,"source":{"system":"sec-edgar","filing":"0001839066-26-000033","document":"wk-form4_1783629938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000033/wk-form4_1783629938.xml","form_type":"4"}},{"id":714306,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-07-06T21:57:34.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":6229,"price":5.26,"value":32764.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the \"RSUs\") on July 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":2834982,"source":{"system":"sec-edgar","filing":"0001839066-26-000031","document":"wk-form4_1783375051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000031/wk-form4_1783375051.xml","form_type":"4"}},{"id":731562,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-06-18T10:42:01.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":2360,"price":4.78,"value":11280.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.87, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.\nRemarks:"}],"balance_after":2841211,"source":{"system":"sec-edgar","filing":"0001839066-26-000024","document":"wk-form4_1781779319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000024/wk-form4_1781779319.xml","form_type":"4"}},{"id":735737,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-06-16T12:14:35.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":6350,"price":4.61,"value":29273.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":2843571,"source":{"system":"sec-edgar","filing":"0001839066-26-000022","document":"wk-form4_1781612073.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000022/wk-form4_1781612073.xml","form_type":"4"}},{"id":741116,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-06-11T21:28:00.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":7289,"price":4.91,"value":35788.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.79 to $5.15, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.\nRemarks:"}],"balance_after":2849921,"source":{"system":"sec-edgar","filing":"0001839066-26-000017","document":"wk-form4_1781213277.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000017/wk-form4_1781213277.xml","form_type":"4"}},{"id":806765,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-04-16T20:09:49.000Z","date":"2026-04-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":12712,"price":2.04,"value":25932.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2857210,"source":{"system":"sec-edgar","filing":"0001839066-26-000015","document":"wk-form4_1776370186.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000015/wk-form4_1776370186.xml","form_type":"4"}},{"id":813095,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-04-07T20:28:10.000Z","date":"2026-04-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6197,"price":1.72,"value":10658.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on April 3, 2026, of 6.25% of the restricted stock units (\"RSUs\") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023.  The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2869922,"source":{"system":"sec-edgar","filing":"0001839066-26-000014","document":"wk-form4_1775593688.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000014/wk-form4_1775593688.xml","form_type":"4"}},{"id":815370,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-04-03T20:34:43.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":159384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A common stock underlying a time-based restricted stock unit award (\"RSUs\"). Twenty-five percent of the RSUs will vest on the first anniversary of April 1, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of April 1, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on April 1, 2030."}],"balance_after":2876119,"source":{"system":"sec-edgar","filing":"0001839066-26-000012","document":"wk-form4_1775248480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000012/wk-form4_1775248480.xml","form_type":"4"}},{"id":834396,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-03-18T22:11:18.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":5833,"price":1.91,"value":11141.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.87 to $1.96, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.\nRemarks:"}],"balance_after":2716735,"source":{"system":"sec-edgar","filing":"0001839066-26-000009","document":"wk-form4_1773871875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000009/wk-form4_1773871875.xml","form_type":"4"}},{"id":836479,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-03-17T20:33:00.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":6187,"price":1.98,"value":12250.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2026, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on September 16, 2022.  The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2722568,"source":{"system":"sec-edgar","filing":"0001839066-26-000007","document":"wk-form4_1773779577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000007/wk-form4_1773779577.xml","form_type":"4"}},{"id":836478,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-03-17T20:33:00.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":8945,"price":1.98,"value":17711.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2026, of the final 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022."}],"balance_after":2728755,"source":{"system":"sec-edgar","filing":"0001839066-26-000007","document":"wk-form4_1773779577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000007/wk-form4_1773779577.xml","form_type":"4"}},{"id":934967,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-01-20T22:38:36.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":4597,"price":2.58,"value":11860.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.47 to $2.63, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2737700,"source":{"system":"sec-edgar","filing":"0001801170-26-000024","document":"wk-form4_1768948713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000024/wk-form4_1768948713.xml","form_type":"4"}},{"id":934966,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-01-20T22:38:36.000Z","date":"2026-01-15","kind":"tax_withholding","planned":true,"acquired":false,"shares":14732,"price":2.81,"value":41396.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2742297,"source":{"system":"sec-edgar","filing":"0001801170-26-000024","document":"wk-form4_1768948713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000024/wk-form4_1768948713.xml","form_type":"4"}},{"id":943878,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-01-07T22:09:56.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":2102,"price":2.53,"value":5318.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.61, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2757029,"source":{"system":"sec-edgar","filing":"0001839066-26-000004","document":"wk-form4_1767823793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000004/wk-form4_1767823793.xml","form_type":"4"}},{"id":949768,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2026-01-05T21:09:35.000Z","date":"2026-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":8109,"price":2.41,"value":19542.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 3, 2026, of 6.25% of the restricted stock units (\"RSUs\") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023.  The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2759131,"source":{"system":"sec-edgar","filing":"0001839066-26-000002","document":"wk-form4_1767647372.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906626000002/wk-form4_1767647372.xml","form_type":"4"}},{"id":962766,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-12-19T00:09:49.000Z","date":"2025-12-18","kind":"sale","planned":true,"acquired":false,"shares":4913,"price":2.61,"value":12822.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.58 to $2.64, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2767240,"source":{"system":"sec-edgar","filing":"0001839066-25-000029","document":"wk-form4_1766102986.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906625000029/wk-form4_1766102986.xml","form_type":"4"}},{"id":966967,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-12-17T00:59:08.000Z","date":"2025-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8691,"price":2.7,"value":23465.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2025, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on September 16, 2022.  The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2772153,"source":{"system":"sec-edgar","filing":"0001839066-25-000027","document":"wk-form4_1765933145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906625000027/wk-form4_1765933145.xml","form_type":"4"}},{"id":966966,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-12-17T00:59:08.000Z","date":"2025-12-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":12567,"price":2.7,"value":33930.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2025, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022.  The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2780844,"source":{"system":"sec-edgar","filing":"0001839066-25-000027","document":"wk-form4_1765933145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906625000027/wk-form4_1765933145.xml","form_type":"4"}},{"id":1006506,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-11-05T21:46:53.000Z","date":"2025-11-04","kind":"sale","planned":true,"acquired":false,"shares":30385,"price":3.58,"value":108778.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.49 to $3.67, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2793411,"source":{"system":"sec-edgar","filing":"0001839066-25-000025","document":"wk-form4_1762379210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906625000025/wk-form4_1762379210.xml","form_type":"4"}},{"id":1007770,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-11-04T22:16:21.000Z","date":"2025-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":29513,"price":3.53,"value":104180.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 31, 2025, of the final 12.5% of RSUs granted to the Reporting Person on October 31, 2023."}],"balance_after":2823796,"source":{"system":"sec-edgar","filing":"0001839066-25-000022","document":"wk-form4_1762294579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906625000022/wk-form4_1762294579.xml","form_type":"4"}},{"id":1007769,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-11-04T22:16:21.000Z","date":"2025-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":101917,"price":3.53,"value":359767.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 50% of the number of earned performance-based restricted stock units (RSU), as described herein.  Each RSU represented a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units vested on October 31, 2025."}],"balance_after":2853309,"source":{"system":"sec-edgar","filing":"0001839066-25-000022","document":"wk-form4_1762294579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906625000022/wk-form4_1762294579.xml","form_type":"4"}},{"id":1015105,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-10-21T20:09:13.000Z","date":"2025-10-17","kind":"sale","planned":true,"acquired":false,"shares":16514,"price":2.69,"value":44422.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.72, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2955226,"source":{"system":"sec-edgar","filing":"0001839066-25-000019","document":"wk-form4_1761077350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906625000019/wk-form4_1761077350.xml","form_type":"4"}},{"id":1016285,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-10-17T20:44:22.000Z","date":"2025-10-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":71432,"price":2.8,"value":200009.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 15, 2025, due to the vesting of 25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2971740,"source":{"system":"sec-edgar","filing":"0001839066-25-000017","document":"wk-form4_1760733859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906625000017/wk-form4_1760733859.xml","form_type":"4"}},{"id":1021925,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-10-07T20:37:42.000Z","date":"2025-10-07","kind":"sale","planned":true,"acquired":false,"shares":2012,"price":2.65,"value":5331.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. These shares were sold at a price of $2.65."}],"balance_after":3043172,"source":{"system":"sec-edgar","filing":"0001801170-25-000240","document":"wk-form4_1759869459.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000240/wk-form4_1759869459.xml","form_type":"4"}},{"id":1021924,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-10-07T20:37:42.000Z","date":"2025-10-03","kind":"tax_withholding","planned":true,"acquired":false,"shares":8706,"price":2.59,"value":22548.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 3, 2025, of 6.25% of the restricted stock units (\"RSUs\") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023.  The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3045184,"source":{"system":"sec-edgar","filing":"0001801170-25-000240","document":"wk-form4_1759869459.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000240/wk-form4_1759869459.xml","form_type":"4"}},{"id":1035302,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-09-19T20:13:04.000Z","date":"2025-09-17","kind":"sale","planned":true,"acquired":false,"shares":4914,"price":3.09,"value":15184.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.06 to $3.13, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3053890,"source":{"system":"sec-edgar","filing":"0001839066-25-000010","document":"wk-form4_1758312781.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906625000010/wk-form4_1758312781.xml","form_type":"4"}},{"id":1038973,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-09-16T21:07:35.000Z","date":"2025-09-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8691,"price":3.14,"value":27289.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 15, 2024, of 6.25% of the restricted stock units granted to the Reporting Person on September 16, 2022, and originally reported on a Form 4 filed on September 20, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on September 16, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3058804,"source":{"system":"sec-edgar","filing":"0001801170-25-000229","document":"wk-form4_1758056852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000229/wk-form4_1758056852.xml","form_type":"4"}},{"id":1038972,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-09-16T21:07:35.000Z","date":"2025-09-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":12567,"price":3.06,"value":38455.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 14, 2025, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022, and originally reported on a Form 4 filed on March 16, 2022.  The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3067495,"source":{"system":"sec-edgar","filing":"0001801170-25-000229","document":"wk-form4_1758056852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000229/wk-form4_1758056852.xml","form_type":"4"}},{"id":1038971,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-09-16T21:00:57.000Z","date":"2025-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":85596,"price":2.79,"value":238812.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to solely to correct that the total number of restricted stock units (RSUs) received upon determination of the level of performance-based RSU grant was previously reported by the Reporting Person on a Form 4/A, filed on January 3, 2024, as described in Footnote 2 below."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 1/3 of the number of earned restricted stock units, as described herein. Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested on September 7, 2023, one-third of the number of earned restricted stock units vested on June 30, 2024, and the remaining one-third of the earned restricted stock units vested on June 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Number reflects total directly held Class A Common Stock taking into account the amended number and transactions through June 30, 2025."}],"balance_after":2887905,"source":{"system":"sec-edgar","filing":"0001839066-25-000008","document":"wk-form4a_1758056455.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906625000008/wk-form4a_1758056455.xml","form_type":"4/A","original_submission_date":"2025-07-02"}},{"id":1038974,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-09-16T21:00:30.000Z","date":"2024-09-13","kind":"grant","planned":false,"acquired":true,"shares":518000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date. This Amendment is being filed solely to reflect the full number of RSUs that were achieved."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Number reflects total directly held Class A Common Stock taking into account the amended number and subsequent transactions through September 15, 2024."}],"balance_after":2531545,"source":{"system":"sec-edgar","filing":"0001839066-25-000007","document":"wk-form4a_1758056426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906625000007/wk-form4a_1758056426.xml","form_type":"4/A","original_submission_date":"2024-09-17"}},{"id":1038970,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-09-16T20:59:59.000Z","date":"2024-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":52967,"price":1.23,"value":65149.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to solely to clarify that the total number of restricted stock units (RSUs) received upon determination of the level of performance-based RSU grant was previously\nreported by the Reporting Person on a Form 4/A, filed on January 3, 2024, as described in Footnote 2 below."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the second tranche of the number of earned restricted stock units, as\ndescribed herein. Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested on September 7, 2023, one-third of the number of earned restricted stock units vested on June 30, 2024, and the remaining one-third of the earned restricted stock units vested on June 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Number reflects total directly held Class A Common Stock taking into account the amended number and transactions through June 30, 2024."}],"balance_after":2401108,"source":{"system":"sec-edgar","filing":"0001839066-25-000006","document":"wk-form4a_1758056396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000183906625000006/wk-form4a_1758056396.xml","form_type":"4/A","original_submission_date":"2024-07-02"}},{"id":1072907,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-08-06T20:59:23.000Z","date":"2025-08-04","kind":"sale","planned":true,"acquired":false,"shares":6823,"price":2.89,"value":19718.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025.  The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.86 to $2.93, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3261485,"source":{"system":"sec-edgar","filing":"0001801170-25-000198","document":"wk-form4_1754513958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000198/wk-form4_1754513958.xml","form_type":"4"}},{"id":1075947,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-08-04T21:31:07.000Z","date":"2025-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":29513,"price":2.89,"value":85292.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 31, 2025, of 12.5% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs have a final vesting date on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3268308,"source":{"system":"sec-edgar","filing":"0001801170-25-000188","document":"wk-form4_1754343063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000188/wk-form4_1754343063.xml","form_type":"4"}},{"id":1090446,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-07-08T21:15:04.000Z","date":"2025-07-07","kind":"sale","planned":true,"acquired":false,"shares":2012,"price":2.85,"value":5734.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.81 to $2.88, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3297821,"source":{"system":"sec-edgar","filing":"0001801170-25-000168","document":"wk-form4_1752009297.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000168/wk-form4_1752009297.xml","form_type":"4"}},{"id":1090445,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-07-08T21:15:04.000Z","date":"2025-07-03","kind":"tax_withholding","planned":true,"acquired":false,"shares":8706,"price":2.56,"value":22287.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on July 3, 2025, of 6.25% of the restricted stock units (\"RSUs\") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3299833,"source":{"system":"sec-edgar","filing":"0001801170-25-000168","document":"wk-form4_1752009297.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000168/wk-form4_1752009297.xml","form_type":"4"}},{"id":1090444,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-07-08T21:15:04.000Z","date":"2025-07-03","kind":"sale","planned":true,"acquired":false,"shares":19789,"price":2.58,"value":51055.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025.  The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.63, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3308539,"source":{"system":"sec-edgar","filing":"0001801170-25-000168","document":"wk-form4_1752009297.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000168/wk-form4_1752009297.xml","form_type":"4"}},{"id":1094035,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-07-02T20:47:50.000Z","date":"2025-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":85596,"price":2.79,"value":238812.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above."}],"balance_after":3328328,"source":{"system":"sec-edgar","filing":"0001801170-25-000165","document":"wk-form4_1751489245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000165/wk-form4_1751489245.xml","form_type":"4"}},{"id":1094034,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-07-02T20:47:50.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":217523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. The final one-third of the number of earned restricted stock units vested and were settled on June 30, 2025."}],"balance_after":3413924,"source":{"system":"sec-edgar","filing":"0001801170-25-000165","document":"wk-form4_1751489245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000165/wk-form4_1751489245.xml","form_type":"4"}},{"id":1105872,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-06-18T21:26:15.000Z","date":"2025-06-17","kind":"sale","planned":true,"acquired":false,"shares":20450,"price":2.86,"value":58487.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025.  The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.82 to $2.92, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3196401,"source":{"system":"sec-edgar","filing":"0001801170-25-000162","document":"wk-form4_1750281969.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000162/wk-form4_1750281969.xml","form_type":"4"}},{"id":1107225,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-06-17T20:36:22.000Z","date":"2025-06-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8691,"price":2.89,"value":25116.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 15, 2025, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on September 16, 2022.  The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3216851,"source":{"system":"sec-edgar","filing":"0001801170-25-000158","document":"wk-form4_1750192547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000158/wk-form4_1750192547.xml","form_type":"4"}},{"id":1107224,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-06-17T20:36:22.000Z","date":"2025-06-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":12567,"price":2.89,"value":36318.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 14, 2025, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022.  The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3225542,"source":{"system":"sec-edgar","filing":"0001801170-25-000158","document":"wk-form4_1750192547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000158/wk-form4_1750192547.xml","form_type":"4"}},{"id":1160694,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-05-02T20:33:22.000Z","date":"2025-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":25659,"price":3.4,"value":87240.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on April 30, 2025, of 12.5% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in two equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3238109,"source":{"system":"sec-edgar","filing":"0001801170-25-000113","document":"wk-form4_1746217990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000113/wk-form4_1746217990.xml","form_type":"4"}},{"id":1176280,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-04-07T20:40:23.000Z","date":"2025-04-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6366,"price":3.51,"value":22344.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on April 3, 2025, of 6.25% of the restricted stock units (\"RSUs\") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023.  The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3263768,"source":{"system":"sec-edgar","filing":"0001801170-25-000079","document":"wk-form4_1744058416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000079/wk-form4_1744058416.xml","form_type":"4"}},{"id":1198199,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-03-18T20:53:29.000Z","date":"2025-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":6354,"price":3.66,"value":23255.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2025, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on September 16, 2022.  The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3270134,"source":{"system":"sec-edgar","filing":"0001801170-25-000073","document":"wk-form4_1742331202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000073/wk-form4_1742331202.xml","form_type":"4"}},{"id":1198198,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-03-18T20:53:29.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":9188,"price":3.66,"value":33628.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2025, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022.  The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3276488,"source":{"system":"sec-edgar","filing":"0001801170-25-000073","document":"wk-form4_1742331202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000073/wk-form4_1742331202.xml","form_type":"4"}},{"id":1283425,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-02-04T21:18:49.000Z","date":"2025-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":21578,"price":4.39,"value":94727.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 31, 2025, of 12.5% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3285676,"source":{"system":"sec-edgar","filing":"0001801170-25-000038","document":"wk-form4_1738703923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000038/wk-form4_1738703923.xml","form_type":"4"}},{"id":1304824,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-01-10T21:10:29.000Z","date":"2025-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":17142,"price":3.6,"value":61711.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2025, due to the vesting of the final 25% of the original number of restricted stock units (\"RSUs\") granted to the Reporting Person on July 16, 2021, and timely reported on a Form 4 filed on July 20, 2021."}],"balance_after":3307254,"source":{"system":"sec-edgar","filing":"0001801170-25-000024","document":"wk-form4_1736543420.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000024/wk-form4_1736543420.xml","form_type":"4"}},{"id":1307425,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2025-01-07T21:12:37.000Z","date":"2025-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":8149,"price":3.29,"value":26810.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 3, 2025, of 6.25% of the restricted stock units (\"RSUs\") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023.  The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3324396,"source":{"system":"sec-edgar","filing":"0001801170-25-000005","document":"wk-form4_1736284350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000005/wk-form4_1736284350.xml","form_type":"4"}},{"id":1327756,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-12-17T21:17:08.000Z","date":"2024-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8691,"price":3.11,"value":27029.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2024, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on September 16, 2022.  The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3332545,"source":{"system":"sec-edgar","filing":"0001801170-24-000248","document":"wk-form4_1734470222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000248/wk-form4_1734470222.xml","form_type":"4"}},{"id":1327755,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-12-17T21:17:08.000Z","date":"2024-12-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":12567,"price":3.11,"value":39083.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2024, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022.  The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3341236,"source":{"system":"sec-edgar","filing":"0001801170-24-000248","document":"wk-form4_1734470222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000248/wk-form4_1734470222.xml","form_type":"4"}},{"id":1376767,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-11-04T22:40:42.000Z","date":"2024-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":118050,"price":4.12,"value":486366.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 31, 2024, of 50% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in four equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3353803,"source":{"system":"sec-edgar","filing":"0001801170-24-000225","document":"wk-form4_1730760036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000225/wk-form4_1730760036.xml","form_type":"4"}},{"id":1384515,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-10-17T20:17:02.000Z","date":"2024-10-15","kind":"grant","planned":false,"acquired":true,"shares":726114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A common stock underlying a time-based restricted stock unit award (\"RSUs\"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028."}],"balance_after":3471853,"source":{"system":"sec-edgar","filing":"0001801170-24-000214","document":"wk-form4_1729196216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000214/wk-form4_1729196216.xml","form_type":"4"}},{"id":1389888,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-10-07T20:39:42.000Z","date":"2024-10-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":8706,"price":4,"value":34824.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 3, 2024, of 6.25% of the restricted stock units (\"RSUs\") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023.  The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2745739,"source":{"system":"sec-edgar","filing":"0001801170-24-000200","document":"wk-form4_1728333576.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000200/wk-form4_1728333576.xml","form_type":"4"}},{"id":1404376,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-09-17T20:06:41.000Z","date":"2024-09-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8691,"price":2.99,"value":25986.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 15, 2024, of 6.25% of the restricted stock units (\"RSUs\") granted to the Reporting Person on September 16, 2022, and originally reported on a Form 4 filed on September 20, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on September 16, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2754445,"source":{"system":"sec-edgar","filing":"0001801170-24-000190","document":"wk-form4_1726603594.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000190/wk-form4_1726603594.xml","form_type":"4"}},{"id":1404375,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-09-17T20:06:41.000Z","date":"2024-09-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":12567,"price":2.99,"value":37575.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 14, 2024, of 6.25% of RSUs granted to the Reporting Person on March 14, 2022, and originally reported on a Form 4 filed on March 16, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on March 14, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2763136,"source":{"system":"sec-edgar","filing":"0001801170-24-000190","document":"wk-form4_1726603594.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000190/wk-form4_1726603594.xml","form_type":"4"}},{"id":1404374,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-09-17T20:06:41.000Z","date":"2024-09-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":101917,"price":2.99,"value":304731.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/2 of the number of earned performance-based restricted stock units, as described above."}],"balance_after":2775703,"source":{"system":"sec-edgar","filing":"0001801170-24-000190","document":"wk-form4_1726603594.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000190/wk-form4_1726603594.xml","form_type":"4"}},{"id":1404373,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-09-17T20:06:41.000Z","date":"2024-09-13","kind":"grant","planned":false,"acquired":true,"shares":259000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date."}],"balance_after":2877620,"source":{"system":"sec-edgar","filing":"0001801170-24-000190","document":"wk-form4_1726603594.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000190/wk-form4_1726603594.xml","form_type":"4"}},{"id":1458094,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-07-08T20:07:33.000Z","date":"2024-07-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":5388,"price":1.25,"value":6735.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on July 3, 2024, of 6.25% of the restricted stock units (\"RSUs\") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023.  The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2618620,"source":{"system":"sec-edgar","filing":"0001801170-24-000149","document":"wk-form4_1720469246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000149/wk-form4_1720469246.xml","form_type":"4"}},{"id":1461960,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-07-02T20:27:46.000Z","date":"2024-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":52967,"price":1.23,"value":65149.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above."}],"balance_after":2624008,"source":{"system":"sec-edgar","filing":"0001801170-24-000145","document":"wk-form4_1719952056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000145/wk-form4_1719952056.xml","form_type":"4"}},{"id":1461959,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-07-02T20:27:46.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":217522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested and were settled on June 30, 2024, and the remaining one-third of the restricted stock units will vest on June 30, 2025, subject to the Reporting Person's continued employment on such vesting date."}],"balance_after":2676975,"source":{"system":"sec-edgar","filing":"0001801170-24-000145","document":"wk-form4_1719952056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000145/wk-form4_1719952056.xml","form_type":"4"}},{"id":1474342,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-06-18T20:59:05.000Z","date":"2024-06-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5378,"price":1.09,"value":5862.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 15, 2024, of 6.25% of the original number of  RSUs granted to the Reporting Person on on September 16, 2022, and timely reported on a Form 4 filed on September 20, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2454075,"source":{"system":"sec-edgar","filing":"0001801170-24-000129","document":"wk-form4_1718744338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000129/wk-form4_1718744338.xml","form_type":"4"}},{"id":1474341,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-06-18T20:59:05.000Z","date":"2024-06-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":7776,"price":1.09,"value":8475.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 14,  2024, of 6.25% of the original number of  RSUs granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2459453,"source":{"system":"sec-edgar","filing":"0001801170-24-000129","document":"wk-form4_1718744338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000129/wk-form4_1718744338.xml","form_type":"4"}},{"id":1546380,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-04-05T20:18:23.000Z","date":"2024-04-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":5387,"price":0.76,"value":4094.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on April 3, 2024, of 6.25% of the restricted stock units (\"RSUs\") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023.  The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2467229,"source":{"system":"sec-edgar","filing":"0001801170-24-000086","document":"wk-form4_1712348291.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000086/wk-form4_1712348291.xml","form_type":"4"}},{"id":1566964,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-03-19T20:12:29.000Z","date":"2024-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5378,"price":0.8,"value":4302.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2024, of 6.25% of the original number of  RSUs granted to the Reporting Person on September 16, 2022, and timely reported on a Form 4 filed on September 20, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2472616,"source":{"system":"sec-edgar","filing":"0001801170-24-000075","document":"wk-form4_1710879131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000075/wk-form4_1710879131.xml","form_type":"4"}},{"id":1571754,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-03-18T20:33:28.000Z","date":"2024-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":7777,"price":0.73,"value":5677.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14,  2024, of 6.25% of the original number of  RSUs granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2477994,"source":{"system":"sec-edgar","filing":"0001801170-24-000069","document":"wk-form4_1710793997.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000069/wk-form4_1710793997.xml","form_type":"4"}},{"id":1682197,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-01-09T21:02:24.000Z","date":"2024-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":16369,"price":0.95,"value":15550.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2024, due to the vesting of 25% of the original number of restricted stock units (\"RSUs\") granted to the Reporting Person on July 16, 2021, and timely reported on a Form 4 filed on July 20, 2021. The remaining RSUs will vest on January 7, 2025, subject to the continued service of the Reporting Person on such date."}],"balance_after":2485771,"source":{"system":"sec-edgar","filing":"0001801170-24-000037","document":"wk-form4_1704834129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000037/wk-form4_1704834129.xml","form_type":"4"}},{"id":1685065,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-01-05T21:07:02.000Z","date":"2024-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":26240,"price":0.92,"value":24140.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 3, 2024, of twenty-five percent of the restricted stock units (\"RSUs\") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023.  The remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after January 3, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2502140,"source":{"system":"sec-edgar","filing":"0001801170-24-000022","document":"wk-form4_1704488797.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000022/wk-form4_1704488797.xml","form_type":"4"}},{"id":1690541,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-01-03T21:33:33.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1559,"price":0.95,"value":1481.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 1, 2024, of the last third of the number of restricted stock units (RSUs) granted to the Reporting Person on January 31, 2022, upon the achievement of certain performance criteria underlying a performance-based RSU\naward that was granted on July 16, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned reflects the amount in the Form 4/A filed on January 3, 2024."}],"balance_after":2528380,"source":{"system":"sec-edgar","filing":"0001801170-24-000013","document":"wk-form4_1704317601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000013/wk-form4_1704317601.xml","form_type":"4"}},{"id":1690540,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2024-01-03T21:30:00.000Z","date":"2023-09-07","kind":"grant","planned":false,"acquired":true,"shares":652566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed solely to correct the number of restricted stock units (RSUs) received upon determination of the level of performance, as described in Footnote 2 below."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023.  One-third of the number of earned RSUs vested and were settled on September 7, 2023, and one-third of the number of earned RSUs will vest on each of June 30, 2024, and June 30, 2025, subject to the Reporting Person's continued employment through each vesting date."}],"balance_after":2033451,"source":{"system":"sec-edgar","filing":"0001801170-24-000012","document":"wk-form4a_1704317375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000012/wk-form4a_1704317375.xml","form_type":"4/A","original_submission_date":"2023-09-11"}},{"id":1704061,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,  Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2023-12-19T22:09:59.000Z","date":"2023-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8691,"price":0.99,"value":8604.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2023, of 6.25% of the original number of  RSUs granted to the Reporting Person on September 16, 2022, and timely reported on a Form 4 filed on September 20, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2529825,"source":{"system":"sec-edgar","filing":"0001801170-23-000123","document":"wk-form4_1703023779.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000123/wk-form4_1703023779.xml","form_type":"4"}},{"id":1706568,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-18T21:51:41.000Z","date":"2023-12-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":12567,"price":1,"value":12567.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2023, of 6.25% of the original number of  time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2538516,"source":{"system":"sec-edgar","filing":"0001801170-23-000118","document":"wk-form4_1702936289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000118/wk-form4_1702936289.xml","form_type":"4"}},{"id":1751024,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-02T20:41:25.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A common stock underlying a time-based restricted stock unit award (\"RSUs\"). Fifty percent of the RSUs will vest on the first anniversary of October 31, 2023, and the remaining RSUs will vest in four equal quarterly installments beginning on the date that is three months after the first anniversary of October 31, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 31, 2025."}],"balance_after":2551083,"source":{"system":"sec-edgar","filing":"0001801170-23-000090","document":"wk-form4_1698957676.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000090/wk-form4_1698957676.xml","form_type":"4"}},{"id":1778591,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"officer":true,"officer_title":"CEO of Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2023-09-18T21:19:30.000Z","date":"2023-09-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":21511,"price":1.13,"value":24307.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 15, 2023, of 25% of the original number of  RSUs granted to the Reporting Person on September 16, 2022, and timely reported on a Form 4 filed on September 20, 2022. The remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after September 15, 2023, in each case subject to the continued service of the Reporting Person on such vesting date."}],"balance_after":1951083,"source":{"system":"sec-edgar","filing":"0000895345-23-000533","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000533/form4.xml","form_type":"4"}},{"id":1778590,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"officer":true,"officer_title":"CEO of Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2023-09-18T21:19:30.000Z","date":"2023-09-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":7776,"price":1.13,"value":8786.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 14, 2023, of 6.25% of the original number of  time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":1972594,"source":{"system":"sec-edgar","filing":"0000895345-23-000533","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000533/form4.xml","form_type":"4"}},{"id":1783609,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"officer":true,"officer_title":"CEO of Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2023-09-11T20:11:17.000Z","date":"2023-09-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":52967,"price":1.31,"value":69386.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above."}],"balance_after":1980370,"source":{"system":"sec-edgar","filing":"0000895345-23-000530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000530/form4.xml","form_type":"4"}},{"id":1783608,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"officer":true,"officer_title":"CEO of Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2023-09-11T20:11:17.000Z","date":"2023-09-07","kind":"grant","planned":false,"acquired":true,"shares":652452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested and was settled on September 7, 2023, and 1/3 of the number of earned restricted stock units will vest on each of June 30, 2024 and June 30, 2025, subject to the reporting person's continued employment through each vesting date."}],"balance_after":2033337,"source":{"system":"sec-edgar","filing":"0000895345-23-000530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000530/form4.xml","form_type":"4"}},{"id":1851187,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"officer":true,"officer_title":"CEO of Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2023-06-16T20:04:15.000Z","date":"2023-06-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":7776,"price":0.94,"value":7309.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 16, 2023, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 17, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":1380885,"source":{"system":"sec-edgar","filing":"0000895345-23-000392","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000392/form4.xml","form_type":"4"}},{"id":1913127,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"officer":true,"officer_title":"CEO of Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2023-04-27T01:56:57.000Z","date":"2022-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1281,"price":2.58,"value":3304.98,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4/A, amends the original Form 4, filed on February 2, 2022, solely to report the number of shares of the Issuer's Class A Common Stock  that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting, on January 31, 2022, of 1/3rd of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on January 31, 2022 upon the achievement of certain performance criteria. The RSUs vest in equal installments on January 31, 2022, January 1, 2023 and January 1, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"The original Form 4 inadvertently omitted the 1,281 shares that were  withheld in connection with the January 31, 2022 vesting event."}],"balance_after":235310,"source":{"system":"sec-edgar","filing":"0000895345-23-000255","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000255/form4.xml","form_type":"4/A","original_submission_date":"2022-02-02"}},{"id":1913126,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"officer":true,"officer_title":"CEO of Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2023-04-27T01:50:21.000Z","date":"2023-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":31455,"price":0.93,"value":29253.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting, on March 14, 2023, of 25% of the original number of RSUs granted to the Reporting Person on March 14, 2022. The remaining RSUs vest in twelve equal quarterly installments beginning on the date that is three months after March 14, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date. The original grant of RSUs was timely reported on a Form 4 filed on Mach 16, 2022."}],"balance_after":1388661,"source":{"system":"sec-edgar","filing":"0000895345-23-000252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000252/form4.xml","form_type":"4"}},{"id":1913125,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"officer":true,"officer_title":"CEO of Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2023-04-27T01:50:21.000Z","date":"2023-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1281,"price":1.33,"value":1703.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting of 1/3rd, of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on January 31, 2022 upon the achievement of certain performance criteria. The original grant was timely reported on a Form 4 filed on July 20, 2021."}],"balance_after":1420116,"source":{"system":"sec-edgar","filing":"0000895345-23-000252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000252/form4.xml","form_type":"4"}},{"id":1913124,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"officer":true,"officer_title":"CEO of Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2023-04-27T01:50:21.000Z","date":"2023-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":16369,"price":1.01,"value":16532.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting of 25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on July 16, 2021, on each of January 7, 2022 and January 7, 2023. The original grant was timely reported on a Form 4 filed on July 20, 2021."}],"balance_after":1421397,"source":{"system":"sec-edgar","filing":"0000895345-23-000252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000252/form4.xml","form_type":"4"}},{"id":1913123,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"officer":true,"officer_title":"CEO of Medicare Advantage"}}],"security":"Class A Common Stock","published_at":"2023-04-27T01:50:21.000Z","date":"2022-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":15830,"price":3.16,"value":50022.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting of 25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on July 16, 2021, on each of January 7, 2022 and January 7, 2023. The original grant was timely reported on a Form 4 filed on July 20, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares of the Issuer's Class A Common Stock reported as beneficially owned includes an adjustment from the most recent Form 4 filing to reflect 1,281 shares of the Issuer's Class A Common Stock withheld by the Issuer to cover the Reporting Person's tax obligations in connection with a prior vesting event that was reported on a Form 4/A filed on the same date as this Form 4 report."}],"balance_after":1437766,"source":{"system":"sec-edgar","filing":"0000895345-23-000252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000252/form4.xml","form_type":"4"}},{"id":2061551,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2023-01-05T21:24:12.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":353982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A common stock underlying a time-based restricted stock unit award (\"RSUs\"). Twenty-five percent of the RSUs will vest on the first anniversary of January 3, 2023, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of January 3, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":1454877,"source":{"system":"sec-edgar","filing":"0001628280-23-000460","document":"wf-form4_167295383214450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000162828023000460/wf-form4_167295383214450.xml","form_type":"4"}},{"id":2153829,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-20T20:39:21.000Z","date":"2022-09-16","kind":"grant","acquired":true,"shares":353356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A common stock underlying a time-based restricted stock unit award (\"RSUs\"). Twenty-five percent of the RSUs will vest on the first anniversary of September 16, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of September 16, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":1100895,"source":{"system":"sec-edgar","filing":"0001628280-22-025244","document":"wf-form4_166370634567239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000162828022025244/wf-form4_166370634567239.xml","form_type":"4"}},{"id":2330097,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-16T22:23:00.000Z","date":"2022-03-14","kind":"grant","acquired":true,"shares":510948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A common stock underlying a time-based restricted stock unit award (\"RSUs\"). Twenty-five percent of the RSUs will vest on the first anniversary of March 14, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of March 14, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":747539,"source":{"system":"sec-edgar","filing":"0001628280-22-006439","document":"wf-form4_164746936511138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000162828022006439/wf-form4_164746936511138.xml","form_type":"4"}},{"id":2415724,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-02T23:55:23.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":15771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A common stock underlying time-based restricted stock units (\"RSUs\") that vest in three equal annual installments on January 31, 2022, January 1, 2023 and January 1, 2024.  On July 16, 2021, the Reporting Person was granted a performance-based restricted stock unit award, and on January 31, 2022, the Talent and Compensation Committee of the Board of Directors certified the achievement of certain of the performance criteria, resulting in the grant of the RSUs."}],"balance_after":236591,"source":{"system":"sec-edgar","filing":"0001628280-22-001707","document":"wf-form4_164384610584079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000162828022001707/wf-form4_164384610584079.xml","form_type":"4"}},{"id":2628870,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-21T01:50:57.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":220820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A common stock underlying a time-based restricted stock unit award (\"RSUs\"). The RSUs will vest in equal annual\ninstallments over four years, beginning on January 7, 2022, subject to the continuous service of the Reporting Person on each vesting date."}],"balance_after":220820,"source":{"system":"sec-edgar","filing":"0000899243-21-029107","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089924321029107/doc4.xml","form_type":"4"}},{"id":2910401,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-01-12T02:15:56.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":465316,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in connection with the Business Combination in exchange for options to acquire 225,000 shares of common stock of Legacy Clover for $9.66 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the stock option is immediately exercisable.  The stock option vests as to 1/5th of the total number of shares on July 27, 2021 and 1/60th of the total number of shares in equal monthly installments thereafter, subject to the continuous service of the Reporting Person on each vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."}],"balance_after":465316,"derivative":{"exercise_price":4.67,"expiration_date":"2030-07-26","underlying":"Class B Common Stock","underlying_shares":465316},"source":{"system":"sec-edgar","filing":"0001209191-21-003163","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000120919121003163/doc4.xml","form_type":"4"}},{"id":2910400,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":29658,"kind":"person","name":"Reynoso Jamie L.","position":1,"cik":"0001839066","reported_name":"Reynoso Jamie L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-01-12T02:15:56.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":51701,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in connection with the Issuer's business combination (the \"Business Combination\") with Clover Health Investments, Corp. (\"Legacy Clover\") in accordance with the terms of the Agreement and Plan of Merger dated as of October 5, 2020, among the Issuer (f/k/a Social Capital Hedosophia Holdings Corp. III), Asclepius Merger Sub Inc., and Legacy Clover, as amended by that certain Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020, in exchange for options to acquire 25,000 shares of common stock of Legacy Clover for $7.57 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the stock option is immediately exercisable.  The stock option vests as to 1/5th of the total number of shares on June 8, 2021 and 1/60th of the total number of shares in equal monthly installments thereafter, subject to the continuous service of the Reporting Person on each vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."}],"balance_after":51701,"derivative":{"exercise_price":3.66,"expiration_date":"2030-06-28","underlying":"Class B Common Stock","underlying_shares":51701},"source":{"system":"sec-edgar","filing":"0001209191-21-003163","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000120919121003163/doc4.xml","form_type":"4"}}]}